Healthcare Services

Metagenomic Sequencing Market Forecast Highlighting Growth Trends And Opportunities

April 23, 2026April 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Metagenomic Sequencing Market In 2026 And 2030?

The metagenomic sequencing market has experienced swift expansion in its size during recent years. This market is expected to grow from $2.5 billion in 2025 to $2.92 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.1%. The historical growth of this market can be attributed to several factors, including the increasing use of NGS, the early adoption of microbial community studies, a rising demand for DNA extraction kits, growth in environmental microbiology research, and the expansion of clinical diagnostics.

The metagenomic sequencing market size is projected to undergo significant expansion over the next few years. It is forecast to reach $5.14 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 15.1%. This growth during the forecast period is attributable to advancements in sequencing technologies, the proliferation of microbiome-based therapeutics, increased investment in bioinformatics, a rising need for cloud-based genomic analysis, and the broader application of precision medicine. Key trends for the forecast period include the expansion of precision genomics facilitated by high-throughput sequencing, the use of AI in metagenomic data analysis, the automation of sample preparation and sequencing workflows, the development of cloud-based bioinformatics platforms for handling large datasets, and IoT-enabled environmental microbiome monitoring.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16117&type=smp

What Major Factors Are Driving The Metagenomic Sequencing Market Forward?

The growing prevalence of tuberculosis (TB) is anticipated to drive the expansion of the metagenomic sequencing market in the future. Tuberculosis is an infectious and communicable illness, caused by Mycobacterium tuberculosis, which predominantly impacts the lungs and transmits via airborne droplets when sick individuals cough or sneeze. The number of TB cases is on the rise, attributed to elements like worldwide migration, compromised immune systems, resistance to antimicrobials, and shortcomings in public health monitoring. Metagenomic sequencing aids in TB identification by allowing for the swift, impartial recognition of pathogens, the discovery of drug-resistance genes, and enhanced tracking of outbreaks, which is vital for handling evolving infectious dangers. As an illustration, in March 2024, data from the Centers for Disease Control and Prevention, a US-based government agency, indicated an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, signifying an uplift of 1,295 cases. Consequently, the increasing incidence of tuberculosis is fueling the expansion of the metagenomic sequencing market.

What Are The Key Segment Divisions In The Metagenomic Sequencing Market Segment Structure?

The metagenomic sequencing market covered in this report is segmented –

1) By Product And Service: Reagents And Consumables, Instruments, Sequencing Services, Analysis And Data Interpretation Solutions

2) By Technology: 16S RNA Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing And De Novo Assembly, Metatranscriptomics

3) By Application: Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Other Applications

Subsegments:

1) By Reagents And Consumables: DNA Or RNA Extraction Kits, Library Preparation Kits, Sequencing Kits, PCR And qPCR Reagents, Other Consumables (Buffers, Probes)

2) By Instruments: Next-Generation Sequencers (NGS), Third-Party Sequencers, Microarrays, Real-Time PCR Instruments

3) By Sequencing Services: Whole Genome Sequencing (WGS), 16S rRNA Sequencing, Shotgun Metagenomic Sequencing, Amplicon Sequencing, Metatranscriptomic Sequencing

4) By Analysis And Data Interpretation Solutions: Bioinformatics Software, Cloud-Based Data Analysis Services, Data Storage Solutions, Custom Analysis Tools, Data Interpretation Platforms

Which Trends Are Impacting The Progress Of The Metagenomic Sequencing Market?

Leading companies in the metagenomic sequencing market are concentrating on developing innovative sequencing services to enhance accuracy, throughput, and cost-effectiveness. These sequencing services represent advanced genomic technologies designed to sequence longer DNA fragments, thereby offering a more thorough perspective on genetic structures compared to conventional short-read techniques. For example, in April 2024, Clinical Microbiomics A/S, a biotechnology company based in Denmark, unveiled sophisticated long-read sequencing services. These services include 16S, ITS, 18S rRNA, custom gene sequencing, and comprehensive genomics and metagenomics, all of which deliver exceptional resolution and quality in microbial analysis. This capability enables detailed insights into microbial communities and aids in the generation of high-quality metagenome-assembled genomes.

Which Organizations Are Engaged In The Metagenomic Sequencing Market?

Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH

Get The Full Metagenomic Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Which Region Is The Largest In The Metagenomic Sequencing Market?

North America was the largest region in the metagenomic sequencing market in 2025. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Metagenomic Sequencing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Browse Through More Reports Similar to the Global Metagenomic Sequencing Market 2026, By The Business Research Company

Pharmacies And Healthcare Stores Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacies-and-healthcare-stores-global-market-report

Digital Health Market Report

https://www.thebusinessresearchcompany.com/report/digital-health-global-market-report

Telehealth Market Report

https://www.thebusinessresearchcompany.com/report/telehealth-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795